Insiders · SOPH

SOPH insider transactions

SOPHiA GENETICS SA (SOPH) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

SOPH insiders

Everyone who has filed a Form 3, 4, 5 or 144 at SOPHiA GENETICS SA, latest first. Follow anyone to get their next filing.

• George CardozaChief Financial Officer+$99K-$53.5K
• Ross MukenChief Executive Officer, Director-$170K
• Philippe MenuChief Medical Officer-$443K
• Zhenyu XuChief Scientific Officer-$725K
• Daan Van WellChief Legal Officer-$116K
• Jurgi CamblongExecutive Chairman, Director-$2.3M
• Kathy L HibbsDirector-$140K
• Abhimanyu VermaChief Technology Officer-$240K
• Manuela ValenteChief People Officer-$149K
• Kevin PuylaertChief Sales Officer-$4,608
• Troy CoxDirector
• Vincent OssipowDirector
• Jean-Michel CosseryDirector
• Didier HirschDirector

Recent Form 3, 4, and 5 filings for SOPH

• 25d
  Chief Medical Officer Menu Philippe sold $36,303 worth of Ordinary Shares (5,000 units at $7.26) as part of a pre-agreed trading plan (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 25d
  Chief Scientific Officer Xu Zhenyu sold $28,727 worth of Ordinary Shares (4,000 units at $7.18) as part of a pre-agreed trading plan (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 25d
  Executive Chairman Camblong Jurgi sold $61,671 worth of Ordinary Shares (8,500 units at $7.26) as part of a pre-agreed trading plan (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 32d
  Chief Technology Officer Verma Abhimanyu sold $42,929 worth of Ordinary Shares (5,284 units at $8.12) as part of a pre-agreed trading plan (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 32d
  Chief People Officer Valente Manuela sold $34,487 worth of Ordinary Shares (4,240 units at $8.13) as part of a pre-agreed trading plan (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 32d
  Chief Legal Officer Van Well Daan sold $50,100 worth of Ordinary Shares (6,168 units at $8.12) as part of a pre-agreed trading plan (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 32d
  Chief Sales Officer Puylaert Kevin sold $1,737 worth of Ordinary Shares (216 units at $8.04) (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 32d
  Chief Medical Officer Menu Philippe sold $60,100 worth of Ordinary Shares (7,394 units at $8.13) as part of a pre-agreed trading plan (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 32d
  Chief Financial Officer Cardoza George sold $12,897 worth of Ordinary Shares (1,592 units at $8.10) as part of a pre-agreed trading plan (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 32d
  Executive Chairman Camblong Jurgi sold $326,526 worth of Ordinary Shares (40,172 units at $8.13) as part of a pre-agreed trading plan (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 32d
  Chief Executive Officer Muken Ross sold $79,971 worth of Ordinary Shares (9,838 units at $8.13) as part of a pre-agreed trading plan (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 32d
  Chief Scientific Officer Xu Zhenyu sold $60,075 worth of Ordinary Shares (7,394 units at $8.12) as part of a pre-agreed trading plan (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 47d
  Chief Executive Officer Muken Ross sold $3,515 worth of Ordinary Shares (422 units at $8.33) as part of a pre-agreed trading plan, decreasing direct ownership by 0.06% to 670,229 units (SEC Form 4) to cover withholding tax

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 47d
  Chief Financial Officer Cardoza George sold $6,447 worth of Ordinary Shares (774 units at $8.33) as part of a pre-agreed trading plan, decreasing direct ownership by 0.25% to 308,318 units (SEC Form 4) (for withholding tax)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 53d
  Chief Medical Officer Menu Philippe sold $39,416 worth of Ordinary Shares (5,000 units at $7.88) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 208,387 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 53d
  Chief Scientific Officer Xu Zhenyu sold $31,538 worth of Ordinary Shares (4,000 units at $7.88) as part of a pre-agreed trading plan, decreasing direct ownership by 0.72% to 552,887 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 55d
  Executive Chairman Camblong Jurgi sold $65,120 worth of Ordinary Shares (8,500 units at $7.66) as part of a pre-agreed trading plan, decreasing direct ownership by 0.25% to 3,435,822 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 55d
  Chief Legal Officer Van Well Daan sold $47,089 worth of Ordinary Shares (6,168 units at $7.63) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 338,884 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 59d
  Director Hibbs Kathy L sold $50,818 worth of Ordinary Shares (6,250 units at $8.13) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 96,992 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 69d
  Chief Scientific Officer Xu Zhenyu sold $89,096 worth of Ordinary Shares (10,000 units at $8.91) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 556,887 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 74d
  Director Hibbs Kathy L sold $54,233 worth of Ordinary Shares (6,250 units at $8.68) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 103,242 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 74d
  Chief Medical Officer Menu Philippe sold $43,396 worth of Ordinary Shares (5,000 units at $8.68) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 213,387 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 74d
  Chief Technology Officer Verma Abhimanyu sold $85,000 worth of Ordinary Shares (10,000 units at $8.50) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 172,171 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 79d
  Chief People Officer Valente Manuela exercised 10,000 units of Ordinary Shares at a strike of $3.20 and sold $79,439 worth of Ordinary Shares (10,000 units at $7.94) as part of a pre-agreed trading plan (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 79d
  Chief Scientific Officer Xu Zhenyu sold $163,482 worth of Ordinary Shares (20,000 units at $8.17) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 566,887 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 86d
  Chief Scientific Officer Xu Zhenyu sold $30,076 worth of Ordinary Shares (4,000 units at $7.52) as part of a pre-agreed trading plan, decreasing direct ownership by 0.68% to 586,887 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 86d
  Chief Medical Officer Menu Philippe sold $37,580 worth of Ordinary Shares (5,000 units at $7.52) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 218,387 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 90d
  Executive Chairman Camblong Jurgi sold $209,209 worth of Ordinary Shares (28,500 units at $7.34) as part of a pre-agreed trading plan, decreasing direct ownership by 0.82% to 3,444,322 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 90d
  Chief Technology Officer Verma Abhimanyu sold $38,000 worth of Ordinary Shares (5,000 units at $7.60) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 182,171 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 93d
  Chief Scientific Officer Xu Zhenyu exercised 10,000 units of Ordinary Shares at a strike of $3.28 and sold $144,924 worth of Ordinary Shares (20,000 units at $7.25) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 590,887 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 95d
  Executive Chairman Camblong Jurgi sold $138,412 worth of Ordinary Shares (20,000 units at $6.92) as part of a pre-agreed trading plan, decreasing direct ownership by 0.57% to 3,472,822 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 95d
  Chief Scientific Officer Xu Zhenyu sold $69,168 worth of Ordinary Shares (10,000 units at $6.92) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 600,887 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 95d
  Chief Technology Officer Verma Abhimanyu sold $34,772 worth of Ordinary Shares (5,000 units at $6.95) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 187,171 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 103d
  Chief Medical Officer Menu Philippe sold $28,306 worth of Ordinary Shares (5,000 units at $5.66) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 223,387 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 109d
  Executive Chairman Camblong Jurgi sold $286,099 worth of Ordinary Shares (44,381 units at $6.45) as part of a pre-agreed trading plan and exercised 4,581 units of Ordinary Shares at a strike of $3.16, decreasing direct ownership by 1% to 3,492,822 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 117d
  Chief Scientific Officer Xu Zhenyu sold $22,819 worth of Ordinary Shares (4,000 units at $5.70) as part of a pre-agreed trading plan, decreasing direct ownership by 0.65% to 610,887 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 117d
  Chief Medical Officer Menu Philippe sold $28,505 worth of Ordinary Shares (5,000 units at $5.70) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 228,387 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 117d
  Executive Chairman Camblong Jurgi sold $47,791 worth of Ordinary Shares (8,500 units at $5.62) as part of a pre-agreed trading plan, decreasing direct ownership by 0.24% to 3,532,622 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 123d
  Executive Chairman Camblong Jurgi sold $93,327 worth of Ordinary Shares (17,685 units at $5.28) as part of a pre-agreed trading plan, decreasing direct ownership by 0.50% to 3,541,122 units (SEC Form 4) to satisfy tax liability

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 124d
  Chief Financial Officer Cardoza George sold $8,419 worth of Ordinary Shares (1,592 units at $5.29) as part of a pre-agreed trading plan, decreasing direct ownership by 0.51% to 309,092 units (SEC Form 4) (tax withholding)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 124d
  Chief People Officer Valente Manuela sold $21,430 worth of Ordinary Shares (4,241 units at $5.05) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 210,450 units (SEC Form 4) (tax liability)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 124d
  Chief Technology Officer Verma Abhimanyu sold $26,957 worth of Ordinary Shares (5,285 units at $5.10) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 192,171 units (SEC Form 4) (tax liability)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 124d
  Chief Scientific Officer Xu Zhenyu sold $38,242 worth of Ordinary Shares (7,393 units at $5.17) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 614,887 units (SEC Form 4) (for withholding tax)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 124d
  Chief Sales Officer Puylaert Kevin sold $1,087 worth of Ordinary Shares (216 units at $5.03), decreasing direct ownership by 0.15% to 147,948 units (SEC Form 4) to satisfy withholding tax

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 124d
  Chief Executive Officer Muken Ross sold $51,354 worth of Ordinary Shares (9,838 units at $5.22) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 670,651 units (SEC Form 4) (tax withholding)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 124d
  Chief Medical Officer Menu Philippe sold $38,156 worth of Ordinary Shares (7,393 units at $5.16) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 233,387 units (SEC Form 4) (withholding tax)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 124d
  Executive Chairman Camblong Jurgi sold $118,164 worth of Ordinary Shares (22,486 units at $5.25) as part of a pre-agreed trading plan, decreasing direct ownership by 0.63% to 3,558,807 units (SEC Form 4) to satisfy tax liability

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 130d
  Executive Chairman Camblong Jurgi exercised 63,479 units of Ordinary Shares at a strike of $3.16 and sold $506,690 worth of Ordinary Shares (83,679 units at $6.06) as part of a pre-agreed trading plan, decreasing direct ownership by 0.56% to 3,581,293 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 132d
  Chief Executive Officer Camblong Jurgi sold $298,155 worth of Ordinary Shares (51,442 units at $5.80) as part of a pre-agreed trading plan and exercised 31,940 units of Ordinary Shares at a strike of $3.16, decreasing direct ownership by 0.54% to 3,601,493 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 135d
  Chief Technology Officer Verma Abhimanyu sold $38,229 worth of Ordinary Shares (6,944 units at $5.51) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 197,456 units (SEC Form 4) (withholding obligation)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 135d
  Chief Medical Officer Menu Philippe sold $27,524 worth of Ordinary Shares (5,000 units at $5.50) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 240,780 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 138d
  Chief Financial Officer Cardoza George sold $4,164 worth of Ordinary Shares (774 units at $5.38) as part of a pre-agreed trading plan, decreasing direct ownership by 0.25% to 310,684 units (SEC Form 4) to satisfy withholding obligation

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 138d
  President Muken Ross sold $2,270 worth of Ordinary Shares (422 units at $5.38) as part of a pre-agreed trading plan, decreasing direct ownership by 0.06% to 680,489 units (SEC Form 4) (for withholding tax)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 139d
  Director Cox Troy was granted 19,724 units of Ordinary Shares, increasing direct ownership by 6% to 328,743 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 139d
  Director Ossipow Vincent was granted 19,724 units of Ordinary Shares, increasing direct ownership by 4% to 522,860 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 139d
  Director Hibbs Kathy L was granted 19,724 units of Ordinary Shares, increasing direct ownership by 22% to 109,492 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 139d
  Director Hirsch Didier was granted 19,724 units of Ordinary Shares, increasing direct ownership by 9% to 240,220 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 139d
  Director Cossery Jean-Michel was granted 19,724 units of Ordinary Shares, increasing direct ownership by 11% to 206,212 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 144d
  Chief Scientific Officer Xu Zhenyu sold $20,056 worth of Ordinary Shares (4,000 units at $5.01) as part of a pre-agreed trading plan, decreasing direct ownership by 0.64% to 622,280 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)
• 146d
  Chief Medical Officer Menu Philippe sold $24,752 worth of Ordinary Shares (5,000 units at $4.95) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 245,780 units (SEC Form 4)

  4 - SOPHiA GENETICS SA (0001840706) (Issuer)